<DOC>
	<DOCNO>NCT02471859</DOCNO>
	<brief_summary>This Phase 1 , Randomized , Double-Blind , Placebo-Controlled , Ascending , Single- Multiple-Oral Dose , Safety , Tolerability , Pharmacokinetic Study GDC-3280 Healthy Subjects .</brief_summary>
	<brief_title>A Safety , Tolerability , Pharmacokinetic Study GDC-3280 Healthy Participants</brief_title>
	<detailed_description />
	<criteria>Is male female , use highly effective contraception Has body mass index ( BMI ) 18.0 30.0 kg/m2 , inclusive Is good general health Having sign informed consent , willing able comply requirement study Does satisfy screen criterion per protocol Is employ related personnel involve trial Has history condition per protocol opinion investigator could compromise participant 's safety analysis result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>